ANGLE plc (LON:AGL – Get Free Report)’s share price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 2.36 and traded as high as GBX 2.90. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares changing hands.
ANGLE Price Performance
The company has a current ratio of 5.19, a quick ratio of 6.18 and a debt-to-equity ratio of 17.22. The company has a fifty day simple moving average of GBX 2.36 and a two-hundred day simple moving average of GBX 4.28. The stock has a market capitalization of £7.58 million, a P/E ratio of -0.49 and a beta of 0.22.
About ANGLE
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Read More
- Five stocks we like better than ANGLE
- Wall Street Stockpicker Names #1 Stock of 2026
- The Best $1 You’ll Spend This Holiday Season
- [URGENT!] SpaceX Going Public! – Pre-IPO Action
- ALERT: Drop these 5 stocks before January 2026!
- The $650 Million Bet on AI’s Future
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
